Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...
A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...
The companies have withdrawn a previous BLA after feedback from regulators at the FDA. The original application was based on ...
The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell therapy.
Results from a late-stage clinical trial are expected in December of this year and, if positive, could reignite Novo shares.
SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...
Q3 2024 Earnings Call Transcript November 6, 2024 Operator: Good day, and thank you for standing by. Welcome to the Third Quarter 2024 Novo Nordisk A/S Earnings Conference Call. At this time, all ...
Novo Nordisk AS (NVO) reports strong financial performance with a 24% sales increase, driven by demand for diabetes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback